Jump to content

Medway School of Pharmacy

Medical examination in a doctor's room

Independent/Supplementary Prescribing (Clinically Enhanced) - PCert

2022

This is a clinically enhanced version of our successful standard non-medical prescribing programme. It is approved by the GPhC and provides a distance learning option for qualification as a clinically enhanced pharmacist independent prescriber. This version of the programme is specifically for pharmacists working in hospital, mental health and community trusts, and for CCG and GP surgery pharmacists. 

Overview

Are you a hospital, mental health or community trust pharmacist? Do you work for a CCG or a GP surgery? This programme has been developed by adapting our regular and well-established prescribing programme and adding a specially designed clinical health and assessment diagnostics module. It is a part-time, blended learning programme which enables pharmacists to qualify as independent prescribers. You develop the knowledge and skills to practise as prescribers with an additional emphasis on clinical skills. On qualification you will meet the RPS Competency Framework for All Prescribers.

Which programme is right for me?

This information is for the CLINICALLY ENHANCED PROGRAMME for hospital, mental health and community trust pharmacists, and for CCG and GP surgery pharmacists. If you are a community pharmacist or a nurse, midwife, physiotherapist, podiatrist, paramedic, radiographer or dietitian please go to our page on the Standard Independent / Supplementary Prescribing Programme. Please note that GP Pharmacists may apply for either programme on a self-funded basis.

Entry points and application deadlines

The Clinically Enhanced Pharmacist Independent Prescribing programme runs over a standard eight months. If you work part-time we can run the programme over an extended period of time. Details can be provided by the administration team.

All application forms are to be emailed to pgtpharmadmin@kent.ac.uk 

Please do not post application forms as we are currently operating a virtual campus.

Cohorts for upcoming academic year (2021/2022)

  • September 2021 start date- deadline 18 June 2021

Teaching

The Prescribing Programme is delivered by distance learning with a total of nine study days at the University, 12 days clinical practice (overseen by a designated medical practitioner) and 20 hours of clinical skills practice (overseen by a clinical supervisor). For more information, download our guide on The Role of the Clinical Supervisor (PDF 200KB).

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

National ratings

In the Research Excellence Framework (REF) 2014, research by the School of Pharmacy was ranked 8th in the UK for research intensity.

An impressive 100% of our research-active staff submitted to the REF and 93% of our research was judged to be of international quality, with 81% of this judged world-leading or internationally excellent. The School’s environment was judged to be conducive to supporting the development of world-leading research.

Project Titles Supervisors
Biological Rhythms and Neuronal Pharmacology Dr Gurprit Lall, Dr Zameel Cader (University of Oxford)
Investigating the biological basis of mucoadhesion, towards developing transmucosal drug delivery systems Dr Francis Brako, Dr Maxwell Casely-Hayford, Dr Elisa Vasilopoulou
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics Dr Simon Scott , Dr Nigel Temperton, Dr Matthew Reeves (UCL)
Formulation of layered silicate-polymer composite particles for the potential oral delivery of biologics Dr Vivek Trivedi, Dr Vadim Sumbayev
Defining the role of thymosin-beta4 as a novel regulator of inflammation in kidney disease Dr Elisa Vasilopoulou
Optimising patient care by improving understanding amongst healthcare professionals of how their patients use herbal medicines Dr Sukvinder Kaur Bhamra, Dr Bob Allkin (Royal Botanic Gardens, Kew), Prof Michael Heinrich (UCL)
Anti-Viral Plastic Antibodies for Diagnostics and Therapeutics Dr Andrew J Hall, Dr Nigel Temperton
Deciphering the landscape of nucleoporin and lamin function in nucleocytoplasmic communication, nuclear scaffolding and transcriptional control in disease prevention Dr Fani Papagiannouli, Dr Gurprit Lall
Synthesis and Biological Evaluation of Tumour Targeting Analogues of Combretastatin A4 Dr M A Casely-Hayford, Dr N Lavignac, Dr V Sumbayev
Computational Neuroscience Investigating the Neurobiological Underpinning of Simple Decision-Making in the Xenopus laevis Tadpole Dr Stella Koutsikou, Dr Joel Tabak-Sznajder (University of Exeter), Prof. Roman Borisyuk (University of Exeter)